Professor Anwen Williams
Projects as PI
- CD59 - A target to arrest age-related cartilage destruction in osteoarthritis (15/10/2010 - 14/10/2011)
- Death receptor 3: A regulator of bone turnover and new target for therapy for osteoporosis? (01/10/2009 - 01/10/2012)
- Does galectin-3 inhibition resynchronize the aberrant vascular constriction responses associated with inflammatory arthritis (01/10/2017 - 30/09/2018)
- Engineering TCRs for greater specifically by targeting the non-CDR framework regions (01/10/2017 - 30/09/2020)
- Galectin-3 inhibition ablates detrimental vascular pathology associated with inflammatory arthritis (01/02/2017 - 31/08/2017)
Projects as Co-Investigator
- Cardiff Institute of Biomechanics and BioEngineering Research (CIBER) (01/10/2009 - 31/03/2015)
- Cardiff Regional Experimental Arthritis Treatment and Evaluation Centre (CREATE Centre) (01/07/2012 - 31/07/2017)
- Defining the efficacy and potency of FE-999301 in experimental inflammatory arthritis (11/03/2013 - 31/05/2014)
- Drug induced stabilisation of RyR2 to improve calcium handling and cardiac function in inherited and acquired cardiac disease (15/09/2015 - 30/09/2020)
- High resolution cabinate x-ray and molecular imaging unit (01/01/2009 - 31/12/2009)